Haitian
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Wang Liang

Tit: Doktè an chèf
Pozisyon: Chèf Divizyon
Pwofil Pèsonèl: Doktè Anchèf, Pwofesè, Sipèvizè Doktora, kounye a Direktè Depatman Ematoloji nan Lopital Peking Tongren. Li te gradye nan Peking Union Medical College an 2010, li te espesyalize nan Medsin Klinik nan sistèm uit ane a, epi li te jwenn diplòm Doktè nan Medsin. Li te angaje nan dyagnostik ak tretman timè ematolojik (lenfom, myelòm miltip, elatriye) pou plis pase 10 ane, epi li gen yon rich eksperyans klinik ak gwo rezilta akademik nan dyagnostik ak tretman divès kalite lenfom ak myelòm, epi li espesyalize nan iminoterapi siblé, chimyoterapi, terapi selil CAR-T, transplantasyon selil souch ematopoyetik, ak dirije devlopman dyagnostik ak tretman miltidisiplinè (MDT). Prensipal enterè rechèch li yo se iminoterapi siblé ak eksplorasyon mekanis rezistans dwòg nan lenfom, epi li te prezide plizyè Fondasyon Nasyonal Syans Natirèl Lachin. Li pibliye plis pase 40 atik pwofesyonèl, ki gen ladan plis pase 30 atik endèkse pa SCI, ki te pibliye nan Lancet Haematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer Therapy Reviews, ak lòt jounal ak jounal. Li pibliye nan Lancet Haematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer, British Journal of Cancer, Annals of Hematology, ak Leukemia & Lymphoma. Li se ko-editè Standard Leukemia Diagnosis and Treatment, Standard Multiple Myeloma Diagnosis and Treatment, ak Medical Oncology. Li te resevwa prim "Respect for Life-2017 Glory to Healers-Youth Innovation Award", prim "Tongren Elite" an 2020, prim "Tongren Hospital Outstanding Young Talent" an 2020, ak premye prim "Tongren Hospital Outstanding Young Talent" an 2020. "Tongren Hospital Outstanding Young Talent" an 2020, '35 Young Oncologists Under 35 with the Most Potential in China'. Afilyasyon akademik: Jèn Manm Branch Ematoloji Asosyasyon Medikal Chinwa a; Manm Pèmanan Komite Iminoterapi Lenfom Sosyete Prevansyon ak Kontwòl Kansè Beijing; Manm Pèmanan Komite Myelom Asosyasyon Edikasyon Medikal Lachin nan; Ekspè Fondasyon Nasyonal Syans Natirèl Lachin. Li se yon editè asosye Aging Pathobiology and Therapeutics, yon manm konsèy editoryal Chinese Journal of Cancer Prevention and Control, yon jèn manm konsèy editoryal Concord Medical Journal, ak yon evalyatè Journal of Hematology & Oncology ak Cancer Biology & Medicine.

Wang Liang